This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: National Taiwan University. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Chuhsing K Hsiao - Innovator in Esophageal Cancer Treatment
Introduction
Chuhsing K Hsiao is an inventor based in Taipei City, Taiwan. He has made significant contributions to the field of medical research, particularly in the area of cancer treatment. His work focuses on developing innovative methods for predicting patient responses to therapies.
Latest Patent Applications
Chuhsing K Hsiao has a notable patent application titled "Biomarkers for predicting response of esophageal cancer patient to chemoradiotherapy." This invention relates to novel genetic markers associated with the response of a patient with esophageal cancer (ECa) to chemoradiation therapy. The application emphasizes methods and kits for predicting an ECa patient's response to chemoradiation therapy through the genotyping of these markers.
Conclusion
Chuhsing K Hsiao's work in identifying biomarkers for esophageal cancer treatment represents a significant advancement in personalized medicine. His innovative approach has the potential to improve treatment outcomes for patients facing this challenging disease.